.
.
of all car-t cell trials registered since 2001, more than half are being conducted in china.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''
.
.
.
.
.